re: Ann: Completion of Rights Issue and Notic... tj,
I wish CEO would say something different. Its like a cut and paste.
Here is my version
"We've partered withwho is providing $2 billion up front with 20% of royalty agreement until 2023. The FDA advises that Nadolol and Zafirlukast inhaled forms have been expidited to market, following a relaxation of FDA rules for drugs with a known safety profile. " said CEO Twigman.
;)))
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
12.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $10.59M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 142 | 13.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.5¢ | 143 | 1 |
View Market Depth
| Last trade - 09.53am 23/06/2025 (20 minute delay) ? |
| IVX (ASX) Chart |
Day chart unavailable